Skip to main content

Fortress Biotech, Inc.

FBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001429260

No open-market purchases or sales by Fortress Biotech, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $17.7M in total; no superinvestor holds it.

Other share classesFBIOP

Q2 2024 vs. Q1 2024

How the institutions holding Fortress Biotech, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of FBIO: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders4050+10
Shares2.93M3.62M+692.9K (+23.6%)
Value$5.61M$6.21M+$599.1K (+10.7%)

New holders (15)

Institutions that held Fortress Biotech, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to FBIO in Q2 2024
InstitutionSharesValue% of portfolio
PVG Asset Management Corp155,675$266.2K1.05%
Cambridge Investment Research Advisors, Inc.88,900$152.0K0.00%
180 Wealth Advisors, LLC62,350$122.8K0.02%
Meridian Wealth Management, LLC65,500$112.0K0.01%
Millennium Management LLC65,176$111.5K0.00%
Atria Investments LLC45,133$77.2K0.00%
Titleist Asset Management, LLC40,080$68.5K0.01%
Prudential Financial Inc21,733$37.2K0.00%
Cassaday & Co Wealth Management LLC20,584$35.2K0.00%
Susquehanna International Group, LLP18,851$32.2K0.00%
Keudell/Morrison Wealth Management13,000$22.2K0.01%
Weaver Consulting Group11,403$19.5K0.01%
SeaCrest Wealth Management, LLC11,000$18.8K0.00%
Citadel Advisors LLC9,295$15.9K0.00%
Tower Research Capital LLC (TRC)960$1.64K0.00%

Sold out (5)

Institutions that held Fortress Biotech, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of FBIO in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Virtu Financial LLC15,310$31.0K
Goldman Sachs Group Inc11,914$23.8K
UBS Group AG3,775$7.55K
Pathway Financial Advisers, LLC250$500
Royal Bank of Canada19$0